Post-approval studies (Phase 4)Study completedNCT00414440
What this trial is testing
Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Novartis Pharmaceuticals 431